Saravanan Yuvaraj
- Molecular Biology
- Genetics top 5%
- Immunology top 10%
- Pathology and Forensic Medicine top 10%
- Oncology
- Co-authors
- Rudi W. HendriksLaurens P. KilMaikel P. PeppelenboschNicolaas A. BosFrank A.E. KruytGodefridus J. PetersKaamar AzijliAnton W. Langerak
- Topics
- Chronic Lymphocytic Leukemia Research (4 papers)Immunodeficiency and Autoimmune Disorders (4 papers)Cell death mechanisms and regulation (4 papers)
- Partner nations
- NetherlandsUnited StatesNorway
In The Last Decade
Saravanan Yuvaraj
15 papers receiving 795 citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Molecular Biology 356
- Genetics 328
- Immunology 293
- Pathology and Forensic Medicine 216
- Oncology 155
Countries citing papers authored by Saravanan Yuvaraj
This map shows the geographic impact of Saravanan Yuvaraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saravanan Yuvaraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saravanan Yuvaraj more than expected).
Fields of papers citing papers by Saravanan Yuvaraj
This network shows the impact of papers produced by Saravanan Yuvaraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saravanan Yuvaraj. The network helps show where Saravanan Yuvaraj may publish in the future.
Co-authorship network of co-authors of Saravanan Yuvaraj
This figure shows the co-authorship network connecting the top 25 collaborators of Saravanan Yuvaraj. A scholar is included among the top collaborators of Saravanan Yuvaraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saravanan Yuvaraj. Saravanan Yuvaraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 13 | |
| 3 | Targeting Bruton's tyrosine kinase in B cell malignanciesbreakdown → | 399 |
| 4 | 42 | |
| 5 | 38 | |
| 6 | Bruton's tyrosine kinase mediated signaling enhances leukemogenesis in a mouse model for chronic lymphocytic leukemia. | 47 |
| 7 | 1 | |
| 8 | 59 | |
| 9 | 11 | |
| 10 | 47 | |
| 11 | 16 | |
| 12 | TRAIL-induced pro- and anti-apoptotic kinase activation in Non small cell lung cancer cells | 18 |
| 13 | 29 | |
| 14 | 61 | |
| 15 | 8 | |
| 16 | 18 |
About Saravanan Yuvaraj
Saravanan Yuvaraj is a scholar working on Immunology, Endocrinology and Genetics, having authored 16 papers that have together received 807 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Cell death mechanisms and regulation (4 papers). The work is most often cited by research in Genetics (328 citations), Immunology (293 citations) and Pathology and Forensic Medicine (216 citations). Saravanan Yuvaraj has collaborated with scholars based in Netherlands, United States and Norway. Frequent co-authors include Rudi W. Hendriks, Laurens P. Kil, Maikel P. Peppelenbosch, Nicolaas A. Bos, Frank A.E. Kruyt, Godefridus J. Peters, Kaamar Azijli, Anton W. Langerak, Carmen Verı́ssima Ferreira and Steven de Jong. Their work appears in journals such as Nature reviews. Cancer, The Journal of Immunology and Journal of Cell Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.